Press release
Opiod Dependence Pipeline Insights, Clinical Trials, and FDA Approvals 2023 (Updated)
Opiod Dependence Pipeline
In the Opiod Dependence Pipeline Report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Opioid Dependence collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Key takeaways from the Opiod Dependence Pipeline Report
• DelveInsight's Opiod Dependence pipeline report depicts a robust space with 35+ active players working to develop 40+ pipeline therapies for Opiod Dependence treatment.
• The leadingOpiod Dependence Companies includes Sen Jam Pharmaceutical, Mindmed, Emergent BioSolutions, Opiant Pharmaceuticals, ATAI Life Sciences, Aphios, Inventage Lab Inc., Trevena Inc., Foresee Pharmaceuticals Co., Ltd, DemeRx, AphioTx Inc., Lyndra Therapeutics, AstraZeneca, Orexo AB, Alar Pharmaceuticals, Ensysce biosciences, Gilgamesh Pharmaceuticals, Indivior, Cerevel Therapeutics, BioCorRx, Kinoxis Therapeutics, Aptinyx, and others.
• Promising Opiod Dependence Pipeline Therapies includes SJP 006, SJP 007, Zolunicant, Naloxone multidose nasal spray, Intranasal nalmefene, Morphine extended release, KUR 101, C4X 3256, APH-1501, IVL3004, TRV734, DMX-1002, FP-004, DMX-NB1, DMX-IB1, LYN-014, LYN-013, AZD4041, OX124, OX125, ALA-1000, ALA-1300, ALA-2000, GM-300X, SBS-226, CVL-354, BICX104, KNX100, NYX-783, and others.
• The Opiod Dependence pipeline companies and academics are working to assess challenges and seek opportunities that could influence R&D Opioid Dependence. The Opiod Dependence pipeline therapies under development are focused on novel approaches to treat/improve Opioid Dependence.
Request a sample and discover the recent breakthroughs happening in the Opiod Dependence Pipeline landscape @ Opiod Dependence Pipeline Outlook Report- https://www.delveinsight.com/report-store/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Opiod Dependence Overview
Opioid use disorder is the chronic use of opioids that causes clinically significant distress or impairment. Opioid use disorders affect over 16 million people worldwide, over 2.1 million in the United States, and there are over 120,000 deaths worldwide annually attributed to opioids. There are as many patients using opioids regularly as there are patients diagnosed with obsessive-compulsive disorder, psoriatic arthritis, and epilepsy in the United States.
Recent Developmental Activities in the Opiod Dependence Treatment Landscape
• OX124 is a powerful naloxone rescue medication, designed to reverse opioid overdoses, including those from highly potent synthetic opioids, such as fentanyl. To meet the target profile for more potent rescue medications, Orexo has developed a novel and unique intranasal formulation technology that allows for rapid and efficient delivery of active ingredients through the intranasal route. Naloxone (OX-124) is under development for the treatment of drug overdose such as opioid overdose. The drug candidate acts by targeting opioid kappa, opioid delta, and opioid Mu receptors. It is administered as a nasal spray. It is developed based on amorphOX technology platform. Currently, the drug in the Preregistration Phase for the treatment of opioid dependence.
• APH-1501, is an investigational drug being developed by Aphios.APH-1501 belongs to the class. It acts as a receptor modulator. APH-1501, a unique, bioactive component of marijuana, in reducing early attrition and improving outcome in opioid-dependent individual in adults diagnosed with an opioid addiction, ages 21-55 years of age. Currently the drug is in Phase II stage of Clinical trial evaluation for the treatment of Opioid Dependence.
For further information, refer to the detailed Opiod Dependence Drugs Launch, Opiod Dependence Developmental Activities, and Opiod Dependence News, click here for Opiod Dependence Ongoing Clinical Trial Analysis- https://www.delveinsight.com/sample-request/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Opiod Dependence Emerging Drugs Profile
• OX 124: Orexo
• APH-1501: Aphios
• DMX-1002: DemeRx IB, Inc.
• Noribogaine: DemeRx IB, Inc.
Opiod Dependence Pipeline Therapeutics Assessment
There are approx. 35+ key companies which are developing the therapies for Opioid Dependence. The companies which have their Opioid Dependence drug candidates in the most advanced stage, i.e. Preregistration Phase include, Orexo.
Find out more about the Opiod Dependence Pipeline Segmentation, Therapeutics Assessment, and Opiod Dependence Emerging Drugs @ Opiod Dependence Treatment Landscape- https://www.delveinsight.com/sample-request/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Opiod Dependence Pipeline Report
• Coverage- Global
• Opiod Dependence Companies- Medicenna Therapeutics, Tarveda Therapeutics, Sen Jam Pharmaceutical, Mindmed, Emergent BioSolutions, GW Pharmaceuticals, Opiant Pharmaceuticals, ATAI Life Sciences, C4X Discovery, and others
• Opiod Dependence Pipeline Therapies- SJP 006, SJP 007, Zolunicant, Naloxone multidose nasal spray, Intranasal nalmefene, Morphine extended release, KUR 101, C4X 3256, and others.
• Opiod Dependence Pipeline Segmentation: Product Type, Molecule Type, Mechanism of Action, Route of Administration
Dive deep into rich insights for drugs for Opiod Dependence Pipeline Companies and Therapies, click here @ Opiod Dependence Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Opioid Dependence: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Opioid Dependence- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Intranasal nalmefene: Opiant Pharmaceuticals
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Drug name: Company name
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. Zolunicant: Mindmed
15. Drug profiles in the detailed report…..
16. Early Stage Products (Preclinical)
17. Sen Jam Pharmaceutical: SJP 007
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Opioid Dependence Key Companies
21. Opioid Dependence Key Products
22. Opioid Dependence- Unmet Needs
23. Opioid Dependence- Market Drivers and Barriers
24. Opioid Dependence- Future Perspectives and Conclusion
25. Opioid Dependence Analyst Views
26. Opioid Dependence Key Companies
27. Appendix
Got Queries? Find out the related information on Opiod Dependence Mergers and acquisitions, Opiod Dependence Licensing Activities @ Opiod Dependence Recent Trends, and Future Perspectives- https://www.delveinsight.com/sample-request/opioid-dependence-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Published Important Links-
https://www.storeboard.com/JohnSmith-5965202
https://doodleordie.com/profile/dennydones99
https://macro.market/company/delveinsight-business-research
https://pantip.com/profile/7306022#topics
https://allmylinks.com/dennydonesusa
https://uconnect.ae/read-blog/4382
https://blacksnetwork.net/post/102497_herpetic-keratitis-is-a-condition-that-affects-the-eye-and-is-caused-by-the-herp.html
https://ekonty.com/-dennydones99
https://app.wedonthavetime.org/posts/03e285b9-e449-4c96-b257-8cb7a2b74243
https://www.weddingbee.com/members/dennydones99/
https://community.storytellingwithdata.com/members/me/gallery
https://www.delveinsight.com/report-store/langerhans-cell-histiocytosis-market
https://www.delveinsight.com/report-store/shigellosis-market
https://www.delveinsight.com/report-store/overactive-bladder-market
https://www.delveinsight.com/report-store/somatotropin-deficiency-market
https://www.delveinsight.com/report-store/herpes-zoster-market
https://www.delveinsight.com/report-store/visual-cycle-modulation-vcm-market
https://www.delveinsight.com/report-store/cataract-surgery-complications-market
https://www.delveinsight.com/report-store/vulvovaginal-candidiasis-market
https://www.delveinsight.com/report-store/erosive-hand-osteoarthritis-market
https://www.delveinsight.com/report-store/tissue-heart-valves-cardiovascular-prosthetic-devices-market
https://www.delveinsight.com/report-store/herpetic-keratitis-market-size
https://www.delveinsight.com/report-store/hot-flashes-in-prostate-cancer-market
https://www.delveinsight.com/report-store/alcoholic-hepatitis-market
https://www.delveinsight.com/report-store/thrombotic-thrombocytopenic-purpura-market
https://www.delveinsight.com/report-store/renal-tubular-acidosis-market
https://www.delveinsight.com/report-store/prostate-cancer-market-insight
https://www.delveinsight.com/report-store/parkinsons-disease-psychosis-market
https://www.delveinsight.com/report-store/hyperphosphatemia-market
https://www.delveinsight.com/report-store/hepatorenal-syndrome-market
https://www.delveinsight.com/report-store/cough-in-idiopathic-pulmonary-fibrosis-ipf-market
https://www.delveinsight.com/report-store/von-hippel-lindau-disease-market
https://www.delveinsight.com/report-store/venous-thromboembolism-market
https://www.delveinsight.com/report-store/urea-cycle-disorders-market
https://www.delveinsight.com/report-store/tendonitis-market
https://www.delveinsight.com/report-store/tendinopathy-market
https://www.delveinsight.com/report-store/systemic-lupus-erythematosus-market
https://www.delveinsight.com/report-store/synovial-sarcoma-market
https://www.delveinsight.com/report-store/smoking-cessation-market
https://www.delveinsight.com/report-store/myopia-progression-market
https://www.delveinsight.com/report-store/herpes-zoster-market
https://www.delveinsight.com/report-store/diabetic-nephropathy-market
https://www.delveinsight.com/report-store/geographic-atrophy-ga-market
https://www.delveinsight.com/report-store/carbapenem-resistant-enterobacteriaceae-infection-market
https://www.delveinsight.com/report-store/hypertrophic-cardiomyopathy-market
https://www.delveinsight.com/report-store/alpha-thalassemia-market
https://www.delveinsight.com/report-store/biliary-atresia-market
https://www.delveinsight.com/report-store/celiac-disease-cd-market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
https://www.delveinsight.com/report-store/chronic-venous-ulceration-market
https://www.delveinsight.com/report-store/familial-adenomatous-polyposis-market
https://www.delveinsight.com/report-store/farbers-disease-market
https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market
https://www.delveinsight.com/report-store/radiotherapy-induced-oral-mucositis-market
https://www.delveinsight.com/report-store/radiation-dermatitis-market
https://www.delveinsight.com/report-store/polymyalgia-rheumatica-market
https://www.delveinsight.com/report-store/peripheral-nerve-injuries-market
https://www.delveinsight.com/report-store/diabetic-gastroparesis-market-size
https://www.delveinsight.com/report-store/type-1-diabetes-market
https://www.delveinsight.com/report-store/systemic-sclerosis-associated-interstitial-lung-disease-ssc-ild-market
https://www.delveinsight.com/report-store/relapsing-refractory-multiple-myeloma-market
https://www.delveinsight.com/report-store/radiation-induced-esophagitis-market-forecast
https://www.delveinsight.com/report-store/parainfluenza-virus-infection-market
https://www.delveinsight.com/report-store/ocular-hypertension-market
https://www.delveinsight.com/report-store/heavy-metal-poisoning-market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers and acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Opiod Dependence Pipeline Insights, Clinical Trials, and FDA Approvals 2023 (Updated) here
News-ID: 3279846 • Views: …
More Releases from DelveInsight Business Research LLP
Scedosporium Infection Market Outlook Report 2032 by DelveInsight | Pfizer, Gile …
DelveInsight's "Scedosporium Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Scedosporium Infection, historical and forecasted epidemiology as well as the Scedosporium Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Scedosporium Infection market report provides current treatment practices, emerging drugs, Scedosporium Infection market share of the individual therapies, and current and forecasted Scedosporium Infection market size…
Negative Pressure Wound Therapy Systems Market Report by DelveInsight | 3M, Card …
Negative Pressure Wound Therapy Systems Market Report by DelveInsight | 3M, Cardinal Health, ConvaTec Group PLC, DeRoyal Industries, Inc., Devon Group, Medela AG, Smith & Nephew PLC, Mölnlycke Health Care AB, Direct Healthcare Group, Accel-Heal Technologies Ltd., B. Braun Melsungen AG, Lohmann & Rauscher, Cenefom Corp., PAUL HARTMANN Asia-Pacific Ltd., Carilex Medical, Chongqing Sunshine Medical Industry and Trading Co., Ltd., Foryou Medical Electronics Co., Ltd., OncoVista Innovative Therapies, Genadyne, Cork…
SGLT2 Inhibitors Market Report 2032 by DelveInsight | Novo Nordisk, AstraZeneca, …
DelveInsight's "SGLT2 Inhibitors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of SGLT2 Inhibitors, historical and forecasted epidemiology as well as the SGLT2 Inhibitors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The SGLT2 Inhibitors market report provides current treatment practices, emerging drugs, SGLT2 Inhibitors market share of the individual therapies, and current and forecasted SGLT2 Inhibitors market size…
Metastatic Castration-Resistant Prostate Cancer Market Outlook Report 2032 by De …
DelveInsight's "Metastatic Castration-Resistant Prostate Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Metastatic Castration-Resistant Prostate Cancer, historical and forecasted epidemiology as well as the Metastatic Castration-Resistant Prostate Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Metastatic Castration-Resistant Prostate Cancer market report provides current treatment practices, emerging drugs, Metastatic Castration-Resistant Prostate Cancer market share of the…
More Releases for Dependence
How is Increasing Dependence on Renewable Resources Driving Thermal Energy Stora …
It has been estimated that the primary energy consumption will increase by 48% in 2040, owing to the surging population and rapid industrialization and urbanization all across the globe. This is highly problematic when the swift decline of fossil fuels is taken into consideration. In addition to this, even if fossil fuels were enough to support the energy demand, their high consumption would cause unrepairable damage to the planet.
Request…
Can India sustain its dependence on oil?
By 2035, India’s oil consumption will double from 7 Billion Barrels per day. Other nations are shifting towards alternative energy sources.
India will contribute a third of the global growth in oil consumption in the next 15 years, and is set to replace China as the largest driver of oil demand growth.
The country is becoming one of the largest oil consumers and is also home to some of the most polluted…
Cocaine Dependence Treatment Market to Observe Strong Development by 2014 - 2020
Cocaine is a psychoactive substance that affects the brain and also suppresses appetite. The substance is abused in different ways, such as by smoking, snorting or injecting. The U.S. National Institute on Drug Abuse’s (NIDA) estimates reveal that in 2007, 13% of all people admitted to drug abuse treatment programs in the U.S. were cocaine abusers. Of all trafficked illegal drugs globally, cocaine ranks second. This has necessitated the introduction…
Rising Dependence on Private Compensation Boosts Agriculture Insurance Market
QYResearchReports declares the addition of a new report based on the global agriculture insurance and reinsurance market to its growing profile. Titled as “Global Agriculture Insurance and Reinsurance Market Size, Status and Forecast 2022,” the report is a study of the market status on the basis of drivers, opportunities and constraints, market segmentation and competitive landscape. The study analyzes the top players in global and major regions that the market…
Financial Dependence And Growths Of Egypt Reinsurance Industry
Latest Market research report on: Egypt Reinsurance Industry | Market Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Timetrics 'Reinsurance in Egypt Key Trends and Opportunities to 2020' report provides detailed analysis of the market trends, drivers and challenges in the Egyptian reinsurance segment.
Download Sample copy of this Report at :http://www.marketresearchreports.biz/sample/sample/1049133
It provides values for key performance indicators such as written premium, reinsurance ceded and reinsurance accepted during the…
Advanced and Predictive Analytics Software Market : Growing Dependence on Big Da …
The intense focus on Hadoop, NoSQL, and NewSQL in a bid to improve enterprises’ operational efficiencies will boost the advanced and predictive analytics (APA) software market worldwide. The implementation of APA helps boost the ability to compute data, thus helping enterprises extract the maximum value from advanced and predictive analytics.
The advanced and predictive analytics (APA) software market stood at US$2,422.9 mn in 2014 and will register an 8.6% CAGR between…
